UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.392

Sortiert nach

Synergistic anti-tumor effects between oncolytic vaccinia virus and paclitaxel are mediated by the IFN response and HMGB1

Gene therapy, 2011-02, Vol.18 (2), p.164-172

2011

Link zum Volltext

Verfügbarkeit prüfen

Sustained inhibition of PKCα reduces intravasation and lung seeding during mammary tumor metastasis in an in vivo mouse model

Oncogene, 2011-01, Vol.30 (3), p.323-333

2011

Link zum Volltext

Verfügbarkeit prüfen

Manipulating the expression of chemokine receptors enhances delivery and activity of cytokine-induced killer cells

British journal of cancer, 2014-04, Vol.110 (8), p.1992-1999

2014

Link zum Volltext

Verfügbarkeit prüfen

Combining immune cell and viral therapy for the treatment of cancer

Cellular and molecular life sciences : CMLS, 2007-06, Vol.64 (12), p.1449-1451, Article 1449

2007

Link zum Volltext

Verfügbarkeit prüfen

CTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma

British journal of cancer, 2015-09, Vol.113 (5), p.747-755

2015

Link zum Volltext

Verfügbarkeit prüfen

Systemic Armed Oncolytic and Immunologic Therapy for Cancer with JX-594, a Targeted Poxvirus Expressing GM-CSF

Molecular therapy, 2006-09, Vol.14 (3), p.361-370

2006

Link zum Volltext

Verfügbarkeit prüfen

Potential for enhanced therapeutic activity of biological cancer therapies with doxycycline combination

Gene therapy, 2013-07, Vol.20 (7), p.770-778

2013

Link zum Volltext

Verfügbarkeit prüfen

Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery

Gene therapy, 2008-05, Vol.15 (10), p.753-758

2008

Link zum Volltext

Verfügbarkeit prüfen

Adaptation to nutrient starvation in Rhizobium leguminosarum bv. phaseoli: analysis of survival, stress resistance, and changes in macromolecular synthesis during entry to and exit from stationary phase

Journal of Bacteriology, 1997-11, Vol.179 (22), p.6894-6901

1997

Link zum Volltext

Verfügbarkeit prüfen

Cell density-dependent starvation survival of Rhizobium leguminosarum bv. phaseoli: identification of the role of an N-acyl homoserine lactone in adaptation to stationary-phase survival

Journal of bacteriology, 1999-02, Vol.181 (3), p.981-990

1999

Link zum Volltext

Verfügbarkeit prüfen

Synergistic Antitumor Effects of Immune Cell-Viral Biotherapy

Science (American Association for the Advancement of Science), 2006-03, Vol.311 (5768), p.1780-1784

2006

Link zum Volltext

Verfügbarkeit prüfen

CTL- vs T sub(reg) lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma

British journal of cancer, 2015-09, Vol.113 (5), p.747-755

2015

Link zum Volltext

Verfügbarkeit prüfen

Modulation of NKG2D-ligand cell surface expression enhances immune cell therapy of cancer

Journal of immunotherapy (1997), 2011-04, Vol.34 (3), p.289

2011

Link zum Volltext

Verfügbarkeit prüfen

Expression of CCL19 from Oncolytic Vaccinia Enhances Immunotherapeutic Potential while Maintaining Oncolytic Activity

Neoplasia (New York, N.Y.), 2012-12, Vol.14 (12), p.1115-IN1

2012

Link zum Volltext

Verfügbarkeit prüfen

Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery: Cellular Vehicles for Gene Therapy

Gene therapy, 2008, Vol.15 (10), p.753-758

2008

Link zum Volltext

Verfügbarkeit prüfen

Sustained inhibition of PKC[alpha] reduces intravasation and lung seeding during mammary tumor metastasis in an in vivo mouse model

Oncogene, 2011-01, Vol.30 (3), p.323

2011

Link zum Volltext

Verfügbarkeit prüfen

Ethyl pyruvate administration inhibits hepatic tumor growth

Journal of leukocyte biology, 2009-09, Vol.86 (3), p.599-607

2009

Link zum Volltext

Verfügbarkeit prüfen

Enhanced Killing of Primary Ovarian Cancer by Retargeting Autologous Cytokine-Induced Killer Cells with Bispecific Antibodies: A Preclinical Study

Clinical cancer research, 2006-03, Vol.12 (6), p.1859-1867

2006

Link zum Volltext

Verfügbarkeit prüfen

Oncolytic Virotherapy: Approaches to Tumor Targeting and Enhancing Antitumor Effects

Seminars in oncology, 2005-12, Vol.32 (6), p.537-548

2005

Link zum Volltext

Verfügbarkeit prüfen

Using in Vivo Bioluminescence Imaging to Shed Light on Cancer Biology

Proceedings of the IEEE, 2005-04, Vol.93 (4), p.750-762

2005

Link zum Volltext
IEEE_Xplore

New enzyme for reductive cancer chemotherapy, YieF, and its improvement by directed evolution

Molecular cancer therapeutics, 2006-01, Vol.5 (1), p.97-103

2006

Link zum Volltext

Verfügbarkeit prüfen

The use of oncolytic vaccinia viruses in the treatment of cancer: a new role for an old ally?

Current gene therapy, 2005-08, Vol.5 (4), p.429

2005

Link zum Volltext

Verfügbarkeit prüfen

A preclinical study of cellular immunotherapy redirected by bispecific antibodies in uterine cell lines and primary cancer cells

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.15044-15044

2006

Link zum Volltext

Verfügbarkeit prüfen

Future directions for the field of oncolytic virotherapy: a perspective on the use of vaccinia virus

Expert opinion on biological therapy, 2004-08, Vol.4 (8), p.1307-1321

2004

Link zum Volltext

Verfügbarkeit prüfen

Cellular immunotherapy redirected by bispecific antibodies in primary ovarian cancer cells: A preclinical study

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.2518-2518

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.392

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.075)
Mit Volltextzugriff
(2.104)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(16)
... seit 30 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Synergistic anti-tumor effects between oncolytic vaccinia virus and paclitaxel are mediated by the IFN response and HMGB1

Sustained inhibition of PKCα reduces intravasation and lung seeding during mammary tumor metastasis in an in vivo mouse model

Manipulating the expression of chemokine receptors enhances delivery and activity of cytokine-induced killer cells

Combining immune cell and viral therapy for the treatment of cancer

CTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma

Systemic Armed Oncolytic and Immunologic Therapy for Cancer with JX-594, a Targeted Poxvirus Expressing GM-CSF

Potential for enhanced therapeutic activity of biological cancer therapies with doxycycline combination

Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery

Adaptation to nutrient starvation in Rhizobium leguminosarum bv. phaseoli: analysis of survival, stress resistance, and changes in macromolecular synthesis during entry to and exit from stationary phase

Cell density-dependent starvation survival of Rhizobium leguminosarum bv. phaseoli: identification of the role of an N-acyl homoserine lactone in adaptation to stationary-phase survival

Synergistic Antitumor Effects of Immune Cell-Viral Biotherapy

CTL- vs T sub(reg) lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma

Modulation of NKG2D-ligand cell surface expression enhances immune cell therapy of cancer

Expression of CCL19 from Oncolytic Vaccinia Enhances Immunotherapeutic Potential while Maintaining Oncolytic Activity

Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery: Cellular Vehicles for Gene Therapy

Sustained inhibition of PKC[alpha] reduces intravasation and lung seeding during mammary tumor metastasis in an in vivo mouse model

Ethyl pyruvate administration inhibits hepatic tumor growth

Enhanced Killing of Primary Ovarian Cancer by Retargeting Autologous Cytokine-Induced Killer Cells with Bispecific Antibodies: A Preclinical Study

Oncolytic Virotherapy: Approaches to Tumor Targeting and Enhancing Antitumor Effects

Using in Vivo Bioluminescence Imaging to Shed Light on Cancer Biology

New enzyme for reductive cancer chemotherapy, YieF, and its improvement by directed evolution

The use of oncolytic vaccinia viruses in the treatment of cancer: a new role for an old ally?

A preclinical study of cellular immunotherapy redirected by bispecific antibodies in uterine cell lines and primary cancer cells

Future directions for the field of oncolytic virotherapy: a perspective on the use of vaccinia virus

Cellular immunotherapy redirected by bispecific antibodies in primary ovarian cancer cells: A preclinical study

Suchergebnisse filtern